| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5842778 | Life Sciences | 2011 | 6 Pages |
Abstract
The correlations between expression levels of receptors and enzymes involved in the sphingosine kinase signalling system in the lung suggest common regulatory mechanisms. Our findings of reduced S1PR5 in COPD and the correlation with other S1P receptors in COPD identify S1PR5 as a possible novel target for pharmacotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fabian Cordts, Stuart Pitson, Christoph Tabeling, Ian Gibbins, David F. Moffat, Hubertus Jersmann, Sandra Hodge, Rainer V. Haberberger,